Galmed Pharmaceuticals Ltd. (GLMD) reporting calendar
Galmed Pharmaceuticals Ltd. files periodic reports with the SEC as GLMD on Nasdaq. Atlas tracks 12 filed reports for this issuer, each linked to its original EDGAR accession.
- Latest report
- 20-F
- Period ended
- 31 Dec 2025
- Filed
- 31 Mar 2026
- Reports on record
- 12
Open GLMD market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 20-F | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001493152-26-014182 |
| 20-F | 31 Dec 2024 | 2 Apr 2025 | 92 days | 0001641172-25-002362 |
| 20-F | 31 Dec 2023 | 4 Apr 2024 | 95 days | 0001493152-24-013203 |
| 20-F | 31 Dec 2022 | 29 Mar 2023 | 88 days | 0001493152-23-009478 |
| 20-F | 31 Dec 2021 | 2 May 2022 | 122 days | 0001493152-22-011729 |
| 20-F | 31 Dec 2020 | 18 Mar 2021 | 77 days | 0001104659-21-038205 |
| 20-F | 31 Dec 2019 | 12 Mar 2020 | 72 days | 0001104659-20-032166 |
| 20-F | 31 Dec 2018 | 13 Mar 2019 | 72 days | 0001144204-19-013601 |
| 20-F | 31 Dec 2017 | 13 Mar 2018 | 72 days | 0001144204-18-014234 |
| 20-F | 31 Dec 2016 | 23 Mar 2017 | 82 days | 0001144204-17-016148 |
| 20-F | 31 Dec 2015 | 22 Mar 2016 | 82 days | 0001144204-16-089349 |
| 20-F | 31 Dec 2014 | 31 Mar 2015 | 90 days | 0001144204-15-019665 |
Source: SEC EDGAR company submissions for CIK 0001595353. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.